Stephenson Cancer Center Revenue and Competitors



Total Funding

Estimated Revenue & Valuation

  • Stephenson Cancer Center's estimated annual revenue is currently $127.2M per year.(i)
  • Stephenson Cancer Center's estimated revenue per employee is $337,500

Employee Data

  • Stephenson Cancer Center has 377 Employees.(i)
  • Stephenson Cancer Center grew their employee count by 13% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Oklahoma's only comprehensive academic cancer center, the Stephenson Cancer Center at the University of Oklahoma is a nationally noted leader in research and patient care. The Stephenson Cancer Center annually ranks among the top three cancer centers in the nation for patients participating in National Cancer Institute-sponsored treatment trials, and it is one of 30 designated lead centers nationally in the Institute's National Clinical Trials Network. In collaboration with the Oklahoma Tobacco Settlement Endowment Trust, the Stephenson Cancer Center is decreasing the burden of cancer in Oklahoma by supporting innovative laboratory, clinical and populations-based research. The Stephenson Cancer Center has 250 research members who are conducting more than 215 cancer research projects at institutions across Oklahoma. This research is supported by $48.3 million in annual funding from the National Cancer Institute, the American Cancer Society and other sponsors.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Stephenson Cancer Center News

2022-04-20 - Multiple Oklahoma agencies partner for study involving home-based blood transfusions

She also fought a list of cancers for decades including lung, breast, ... Integris and Apex Hospice and OU's Stephenson Cancer Center.

2022-04-17 - OU Health Stephenson Cancer Center marks milestone

The Stephenson Cancer Center is a national leader in early-and late-phase clinical trials and is one of 32 lead academic participating sites in...

2022-04-13 - OncXerna Therapeutics Announces Journal of Clinical Oncology Publication Featuring Phase 1b Data of Navicixizumab Plus Paclitaxel in Ovarian Cancer

OncXerna Therapeutics Announces Journal of Clinical Oncology Publication ... at The Stephenson Cancer Center, The University of Oklahoma.

2019-09-12 - OU researcher creating novel device for early detection of oral ...

Robert Mannel, M.D., Stephenson Cancer Center director and Rainbolt Family Chair in Cancer, said Jo's research has the potential to ...

2019-09-12 - OU researcher to create new device for early detection of cancer

A researcher at the Stephenson Cancer Center at OU Medicine is developing a new technology that will aid in the early detection of oral cancer ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding